For the Inventor, By the Inventor

Enter assignee name

Omaha, NE, United States of America

Transgenomic, Inc.

USPTO Granted Patents = 69

EPO Patents = 1

Trademarks = 2

Forward Citations = 520

Loading Chart...

Loading Chart...

47 inventors (with patents filed for the assignee):

Douglas T Gjerde (49 out of 102 patents)

Paul D Taylor (36 out of 37 patents)

Robert M Haefele (31 out of 31 patents)

4. David W Togami (11 out of 11 patents)

5. Christopher P Hanna (8 out of 16 patents)

6. Robert C Fry (4 out of 10 patents)

7. David P Hornby (4 out of 4 patents)

8. John E Sutton (4 out of 4 patents)

9. Gary Floyd Gerard (4 out of 21 patents)

10. Xue-Feng Pei (3 out of 3 patents)

11. Baoqing Li (3 out of 3 patents)

12. Maria-Luisa Maccecchini (3 out of 9 patents)

13. Karl H Hecker (3 out of 3 patents)

14. Kimberly A Lamb (3 out of 3 patents)

15. Arthur P D'Silva (3 out of 10 patents)

Core Competencies:

COLD-PCR Enrichment

Long QT Syndrome

Variant Nucleotides

CEL II Endonuclease

Polynucleotide Chromatography

Liquid Chromatography

Mutation Analysis

DNA Separation

RNA Analysis

Electrophoresis

cDNA Preparation

Polynucleotide Purification

69 patents: Sort by Forward Citations

1. 9133490 - Step-up method for COLD-PCR enrichment (2015-09-15),

2. 8658358 - Mutations associated with long QT syndrome (2014-02-25),

3. 7749708 - Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule (2010-07-06),

4. 7579155 - Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule (2009-08-25),

5. 7560261 - Nucleic acid sequences encoding CEL II endonuclease (2009-07-14),

6. 7225079 - System and method for automated matched ion polynucleotide chromatography (2007-05-29),

7. 7169298 - Method and apparatus for separating polynucleotides using monolithic capillary columns (2007-01-30),

8. 7138518 - Liquid chromatographic separation of polynucleotides (2006-11-21),

9. 7135289 - Methods and compositions for mutation analysis of polynucleotides by liquid chromatography (2006-11-14),

10. 7129075 - Isolated CEL II endonuclease (2006-10-31),

11. 6894048 - Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors (2005-05-17),

12. 6887867 - 5H-2,3-benzodiazepine antagonists of excitatory amino acid receptors (2005-05-03),

13. 6838242 - Modifying double stranded DNA to enhance separations by matched ion polynucleotide chromatography (2005-01-04),

14. 6737022 - Fragment collector apparatus (2004-05-18),

15. 6703390 - Sulfur containing dihydrophthalazine antagonists of excitatory amino acid receptors (2004-03-09),

Transgenomic, Inc. is a global biotechnology company specializing in genetic variation analysis. They provide advanced molecular diagnostic tests, genetic analysis tools, and clinical and research services to assist researchers, clinicians, and healthcare professionals in disease identification and treatment. With a focus on personalized medicine, Transgenomic aims to improve patient outcomes through innovative genomic technologies and solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

69 Patents

#8 in Omaha, NE

#16 in Nebraska

#5,083 in US

#10,329 in the World

Omaha, NE, United States of America

Transgenomic, Inc.

Forward Citations = 520

47 inventors:

Douglas T Gjerde (49 out of 102 patents)

Paul D Taylor (36 out of 37 patents)

Robert M Haefele (31 out of 31 patents)

4. David W Togami (11 out of 11 patents)

5. Christopher P Hanna (8 out of 16 patents)

Please report any incorrect information to support@idiyas.com

Loading…